128-46-1

128-46-1 structure
128-46-1 structure
  • Name: Dihydrostreptomycin
  • Chemical Name: dihydrostreptomycin
  • CAS Number: 128-46-1
  • Molecular Formula: C21H41N7O12
  • Molecular Weight: 583.590
  • Catalog: API Antibiotics Aminoglycoside
  • Create Date: 2018-07-04 18:50:42
  • Modify Date: 2024-01-12 07:35:20

Name dihydrostreptomycin
Synonyms Dihydrostreptomycin
Abiocine
Dihydrostreptomycine
Panstreptin
DST
dhms
O-2-Deoxy-2-(methylamino)-a-L-glucopyranosyl-(1®2)-O-5-deoxy-3C-(hydroxymethyl)-a-L-lyxofuranosyl-(1®4)-N,N'-bis(aminoiminomethyl)-D-streptamine
Acetonitrile,2-benzimidazolyl
dihydro-streptomyci
1,1'-[(1R,2R,3S,4R,5R,6S)-4-({5-Deoxy-2-O-[2-deoxy-2-(methylamino)-α-L-glucopyranosyl]-3-C-(hydroxymethyl)-α-L-lyxofuranosyl}oxy)-2,5,6-trihydroxy-1,3-cyclohexanediyl]diguanidine
Guanidine, N,N'''-[(1R,2R,3S,4R,5R,6S)-4-[[5-deoxy-2-O-[2-deoxy-2-(methylamino)-α-L-glucopyranosyl]-3-C-(hydroxymethyl)-α-L-lyxofuranosyl]oxy]-2,5,6-trihydroxy-1,3-cyclohexanediyl]bis-
Vibriomycin
1,1'-[(1R,2R,3S,4R,5R,6S)-4-({5-Deoxy-2-O-[2-deoxy-2-(methylamino)-α-L-glucopyranosyl]-3-C-(hydroxymethyl)-α-L-lyxofuranosyl}oxy)-2,5,6-trihydroxycyclohexane-1,3-diyl]diguanidine
MFCD00084778
Benzimidazole,2-cyanomethyl
UNII-P2I6R8W6UA
EINECS 204-888-2
DHSM
Density 2.0±0.1 g/cm3
Boiling Point 879.5±75.0 °C at 760 mmHg
Melting Point 210 - 212ºC
Molecular Formula C21H41N7O12
Molecular Weight 583.590
Flash Point 485.7±37.1 °C
Exact Mass 583.281311
PSA 334.59000
LogP -3.38
Vapour Pressure 0.0±0.6 mmHg at 25°C
Index of Refraction 1.762

CHEMICAL IDENTIFICATION

RTECS NUMBER :
WK2450000
CHEMICAL NAME :
Streptamine, O-beta-D-mannopyranosyl-(1-4)-2-deoxy-2-(methylamino) -alpha-L-glucopyranos yl- (1-2)-5-deoxy-O-3-C-(hydroxymethyl)-alpha-L-lyxofuran osyl-(1-4)-N,N'-diami dino-, D-
CAS REGISTRY NUMBER :
128-46-1
LAST UPDATED :
199603
DATA ITEMS CITED :
11
MOLECULAR FORMULA :
C21-H41-N7-O12
MOLECULAR WEIGHT :
583.69
WISWESSER LINE NOTATION :
T6OTJ CM1 DQ EQ F1Q BO- CT5OTJ DQ D1Q E1 BO- AL6TJ BQ CQ DMYZUM EQ FMYZUM

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
200 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
533 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
1180 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
200 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intramuscular
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
350 mg/kg
TOXIC EFFECTS :
Behavioral - convulsions or effect on seizure threshold
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Unreported
DOSE :
260 mg/kg
SEX/DURATION :
female 19-22 week(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - eye/ear
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Unreported
DOSE :
400 mg/kg
SEX/DURATION :
female 1-16 week(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - eye/ear
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
DOSE :
600 mg/kg
SEX/DURATION :
female 6-10 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - litter size (e.g. # fetuses per litter; measured before birth) Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death, e.g., stunted fetus) Reproductive - Effects on Embryo or Fetus - fetal death
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intramuscular
DOSE :
7500 mg/kg
SEX/DURATION :
female 5-19 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - eye/ear
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intraperitoneal
DOSE :
12 gm/kg
SEX/DURATION :
female 1-20 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Newborn - stillbirth Reproductive - Effects on Newborn - viability index (e.g., # alive at day 4 per # born alive)

MUTATION DATA

TEST SYSTEM :
Rodent - mouse
DOSE/DURATION :
100 mg/kg
REFERENCE :
NULSAK Nucleus (Calcutta). (Dr. A.K. Sharma, Centre of Advanced Studies in Cell and Chromosome Research, Calcutta, 35 Baliygunge Circular Rd., Calcutta 700 019, India) V.1- 1958- Volume(issue)/page/year: 14,161,1971

~%

128-46-1 structure

128-46-1

Literature: Kagaku Kenkyusho Hokoku, , vol. 28, p. 103,106, 199, 316 Rep. scient. Res. Inst. Abstr. Tokyo, , vol. 22, p. 6,7